Chem Path Flashcards
<p></p>
<p>List 3 roles of purines</p>
<p></p>
<p>Genetic code, 2nd messengers for hormone action (e.g. cAMP), energy transfer (e.g. ATP)</p>
<p></p>
<p>Describe pathway of purine catabolism (include enzymes & substrate names)</p>
<p></p>
<p>Purines -> hypoxanthine -> xanthine -> urate -> allantoin
<br></br>
<br></br>- Xanthine oxidase: hypoxanthine -> urate
<br></br>- Uricase: urate -> allantoin</p>
<p></p>
<p>Which enzyme typically leads to build-up of uric acid?</p>
<p></p>
<p>Uricase
<br></br>N.B: Allantoin (product of uricase) = soluble & rapidly excreted in urine</p>
<p></p>
<p>Why are M more susceptible to gout than F?</p>
<p></p>
<p>Higher average urate plasma concentrations</p>
<p></p>
<p>Which joint is most commonly affected by gout & why?</p>
<p></p>
<p>1st metatarsophalangeal joint - found at periphery so likely to be cooler (lower temperatures reduce concentration at which urate precipitates out of solution)</p>
<p></p>
<p>Describe how kidneys handle urate.</p>
<p></p>
<p>Proximal convoluted tubule reabsorbs & secretes urate
<br></br>N.B: Reason urate reabsorbed probably because it's an important antioxidant that protects from oxidative stress</p>
<p></p>
<p>Roughly what proportion of filtered urate will be found in urine? What term is used to describe this?</p>
<p></p>
<p>10%
<br></br>Fractional excretion of uric acid (FEUA)</p>
<p></p>
<p>What are the 2 methods of purine synthesis? Which is predominant in most tissues?</p>
<p></p>
<p>De novo synthesis
<br></br>Salvage pathway (predominant)</p>
<p></p>
<p>Describe de novo purine synthesis. In which tissue is this dominant?</p>
<p></p>
<p>Metabolically demanding & inefficient.
<br></br>Only occurs when high demand for purines (e.g. bone marrow)</p>
<p></p>
<p>What is rate limiting step in de novo purine synthesis pathway?</p>
<p></p>
<p>PAT (polar auxin transport)</p>
<p></p>
<p>Describe the inhibitory & stimulatory controls on this enzyme</p>
<p></p>
<p>AMP & GMP negatively regulate PAT activity
<br></br>PPRP positively regulates PAT activity</p>
<p></p>
<p>What is the main enzyme in the salvage pathway? Describe its role.</p>
<p></p>
<p>HPRT (aka HGPRT)
<br></br>Mops up partially catabolised purines & brings them back up metabolic pathway to produce IMP & GMP
<br></br>N.B: Hypoxanthine -> IMP; guanine -> GMP</p>
<p></p>
<p>What inborn error of purine metabolism is characterised by HPRT deficiency?</p>
<p></p>
<p>Lesch-Nyhan syndrome</p>
<p></p>
<p>Describe Lesch-Nyhan syndrome's inheritance pattern</p>
<p></p>
<p>X-linked recessive (must say recessive not just X-linked)</p>
<p></p>
<p>Outline clinical features of Lesch-Nyhan syndrome</p>
<p></p>
<p>Normal at birth
<br></br>Developmental delay at 6mths
<br></br>Hyperuricaemia
<br></br>Choreiform movements at 1yr
<br></br>Spasticity & mental retardation
<br></br>Self-multilation present in 85% (e.g. biting lips very hard)</p>
<p></p>
<p>Describe the biochemical basis of Lesch-Nyhan syndrome</p>
<p></p>
<p>Caused by absolute deficiency of HPRT
<br></br>Reduces production of AMP & GMP by salvage pathway
<br></br>Reduces inhibitory effect of AMP & GMP on PAT, thereby increasing activity of de novo pathway
<br></br>Leads to production of vast amounts of IMP, which will be shunted down catabolic pathway to produce urate (which accumulates)
<br></br>Less conversion of guanine -> GMP leads to build-up of PPRP (which stimulates PAT)</p>
<p></p>
<p>What are the 2 mechanisms of hyperuricaemia? List some examples</p>
<p></p>
<p>Increased urate production
<br></br>- E.g. rapid cell turnover in myeloproliferative diseases & psoriasis
<br></br>
<br></br>Decreased urate excretion
<br></br>- E.g. saturnine gout (caused by lead poisoning e.g. antifreeze) and diuretic use</p>
<p></p>
<p>What are the 2 types of gout?</p>
<p></p>
<p>Acute (podagra)
<br></br>Chornic (tophaceous)
<br></br>N.B: Tophi can cause periosteal bone erosion</p>
<p></p>
<p>How can gout be diagnosed if there is still doubt after history, examination, & measurement of uric acid levels?</p>
<p></p>
<p>Effusion can be tapped & viewed under polarised light using red light compensator</p>
<p></p>
<p>What is birefringence?</p>
<p></p>
<p>Ability of crystal to rotate axis of polarised light
<br></br>-ve = appear blue at 90 degrees to axis of red compensator
<br></br>+ve = appear blue in axis of red compensator</p>
<p></p>
<p>Describe how birefringence/crystals differ between gout & pseudogout?</p>
<p></p>
<p>Gout - monosodium urate crystals - needle-shaped & -vely birefringent
<br></br>
<br></br>Pseudogout - calcium pyrophosphate crystals - rhomboid shaped & +vely birefringent</p>
<p></p>
<p>List 3 drug classes used in the acute management of gout</p>
<p></p>
<p>NSAIDs
<br></br>Colchicine
<br></br>Glucocorticoids</p>
<p></p>
<p>Describe mechanism of colchicine</p>
<p></p>
<p>Inhibits manufacture of tubulin
<br></br>Short-term administration of colchicine inhibits microtubule formation enough to reduce motility of neutrophils (thereby reducing ability to migrate to site of inflammation)</p>
<p></p>
<p>Describe management of gout after acute phase over</p>
<p></p>
<p>Encourage fluid intake
<br></br>Reverse factors that may increase concentration of uric acid (e.g. stopping diuretics)
<br></br>
<br></br>Allopurinol - reduces synthesis of urate by inhibiting xanthine oxidase
<br></br>Probenecid - increases renal excretion of urate (increases FEUA)</p>
<p></p>
<p>Which drug is contraindicated with allopurinol?</p>
<p></p>
<p>Azathioprine</p>
<p></p>
<p>Describe interaction between allopurinol & azathoioprine</p>
<p></p>
<p>Azathioprine = pro-drug that's metabolised to merceptopurine & thioinosate
<br></br>Mercaptopurine (being a purine) metabolised by xanthine oxidase pathway
<br></br>Inhibiting xanthine oxidase with allopurinol leads to build-up of mercaptopurine resulting in bone marrow toxicity</p>
<p></p>
<p>What underlying condition is pseudogout often associated with?</p>
<p></p>
<p>Osteoarthritis
<br></br>N.B: Self-limiting & usually resolves after 1-3wks</p>
<p></p>
<p>What are features of atherosclerotic lesion?</p>
<p></p>
<p>Fibrous cap
<br></br>Foam cells (macrophages full of cholesteryl ester)
<br></br>Necrotic core (full of cholesterol crystals)</p>
<p></p>
<p>During what time will chylomicrons be most abundunt?</p>
<p></p>
<p>After eating (present in very small amounts in fasted state)</p>
<p></p>
<p>Describe uptake of cholesterol by intestinal epithelium</p>
<p></p>
<p>Cholesterol entering intestines will come from diet & bile
<br></br>Cholesterol will be solubilised in mixed micelles
<br></br>Then transported across intestinal epithelium by NPC1L1 (this is main determinant of cholesterol transport)</p>
<p></p>
<p>Where are bile acids absorbed?</p>
<p></p>
<p>Terminal ileum</p>
<p></p>
<p>What happens when cholesterol arrives at liver?</p>
<p></p>
<p>Downregulates activity of HMG CoA reductase
<br></br>N.B: This is responsible for production of cholesterol from acetate & mevalonic acid</p>
<p></p>
<p>What are the 2 fates of cholesterol that either produced by or transported to the liver?</p>
<p></p>
<p>Hydroxylation by 7a-hydroxylase to produce bile acids
<br></br>Esterification by ACAT to produce cholesterol ester which is incorporated into VLDLs along with triglycerides & ApoB</p>
<p></p>
<p>What are effects of CETP on movement of substances between lipoproteins?</p>
<p></p>
<p>Moves cholesterol from HDL -> VLDL
<br></br>Moves triglycerides from VLDL -> HDL</p>
<p></p>
<p>Describe transport & metabolism of triglycerides</p>
<p></p>
<p>Triglycerides from fatty foods hydrolysed to fatty acids, absorbed, & resynthesised into triglycerides which transported by chylomicrons into plasma
<br></br>Chylomicrons hydrolysed by lipoprotein lipase into free fatty acids
<br></br>Some free fatty acids taken up by liver & some by adipose tissue
<br></br>Liver resynthesises fatty acids into triglycerides & packages them into VLDLs
<br></br>VLDLs acted upon by lipoprotein lipase to liberate free fatty acids</p>
<p></p>
<p>List the 3 causes of familial hypercholesterolaemia (type II)</p>
<p></p>
<p>Caused by autosomal dominant gene mutations in:
<br></br>- LDL receptor
<br></br>- ApoB
<br></br>- PCSK9</p>
<p></p>
<p>List some mutations implicated in polygenic hypercholesterolaemia</p>
<p></p>
<p>NPC1L1
<br></br>HMGCR
<br></br>CYP7A1</p>
<p></p>
<p>What is familial hyperalpha lipoproteinaemia?</p>
<p></p>
<p>Increase in HDL caused by deficiency of CETP
<br></br>Associated with longevity</p>
<p></p>
<p>What is phytosterolaemia?</p>
<p></p>
<p>Increased plasma concentrations of plant sterols due to mutations in ABC G5 & ABC G8
<br></br>N.B: This condition associated with premature atherosclerosis</p>
<p></p>
<p>Describe function of LDL receptor</p>
<p></p>
<p>LDLs bind to LDLR in coated pits which then undergo endocytosis (thereby uptaking LDL into liver)</p>
<p></p>
<p>List some clinical features of familial hypercholesterolaemia</p>
<p></p>
<p>Xanthelasma
<br></br>Corneal arcus
<br></br>Tendon xanthomata</p>
<p></p>
<p>What is PCSK9?</p>
<p></p>
<p>Protein that binds to LDL receptors & degrades them
<br></br>N.B: Gain of function mutations result in increased breakdown of LDLR & hence increased plasma LDL levles</p>
<p></p>
<p>List key features of the following forms of familial hypertriglyceridaemia:
<br></br>- Familial Type I
<br></br>- Familial Type IV
<br></br>- Familial Type V</p>
<p></p>
<p>Familial type I
<br></br>- Caused by deficiency of lipoprotein lipase & ApoCII
<br></br>- N.B: Lipoprotein lipase degrades chylomicrons & ApoCII is an activator of lipoprotein lipase
<br></br>
<br></br>Familial type IV
<br></br>- Characterised by increased synthesis of triglycerides
<br></br>
<br></br>Familial type V
<br></br>- Characterised by deficiency of ApoA V
<br></br>
<br></br>N.B: These hypertriglyceridaemias show different different patterns when plasma left overnight to separate</p>
<p></p>
<p>What is familial combined hyperlipidaemia?</p>
<p></p>
<p>Some people in family have high cholesterol & others have high triglycerides</p>
<p></p>
<p>What is familial dysbetalipoproteinaemia (type III)?</p>
<p></p>
<p>Due to aberrant form of ApoE (E2/2)
<br></br>N.B: Normal form is ApoE (3/3)
<br></br>Diagnostic clinical feature = yellowing of palmar crease (palmar striae)</p>
<p></p>
<p>List some causes of secondary hyperlipidaemia</p>
<p></p>
<p>Pregnancy
<br></br>Hypothyroidism
<br></br>Obesity
<br></br>Nephrotic syndrome</p>
<p></p>
<p>List 4 causes of hypolipidaemia & their underlying genetic defect</p>
<p></p>
<p>ab (alpha beta)-lipoproteinaemia
<br></br>- Autosomal recessive
<br></br>- Extremely low levels of cholesterol
<br></br>- Due to deficiency of MTP
<br></br>
<br></br>Hypo-b-lipoproteinaemia
<br></br>- Autosomal dominant
<br></br>- Low LDL
<br></br>- Caused by mutations in ApoB
<br></br>
<br></br>Tangier disease
<br></br>- Low HDL
<br></br>- Caused by mutation of ABC A1
<br></br>
<br></br>Hypo-a-lipoproteinaemia
<br></br>- Sometimes caused by mutation of ApoA1</p>
<p></p>
<p>Describe the role of LDL in atherosclerosis</p>
<p></p>
<p>LDL becomes oxidised once it has got through vascular endothelium
<br></br>Once oxidised taken up by macrophages
<br></br>Within the macrophages, the LDLs become esterified & develop foam cells</p>
<p></p>
<p>List some lipid-lowering drugs & their effect on lipid levels</p>
<p></p>
<p>Statins - reduce LDLs, increase HDLs, slight increase in triglycerides
<br></br>Fibrates - lower triglycerides, little effects on LDL/HDL
<br></br>Ezetimibe - reduces cholesterol absorption (blocks NPC1L1)
<br></br>Colestyramine - resin that binds to bile acids & reduces their absorption</p>
<p></p>
<p>List some novel form of lipid-lowering drugs</p>
<p></p>
<p>Lomitapide - MTP blocker
<br></br>REGN727 - anti-PCSK9 monoclonal Ab
<br></br>Mipomersen - anti-sense ApoB oligonucleotide</p>
<p></p>
<p>What is the definition of success in bariatric surgery?</p>
<p></p>
<p>>50% reduction in excess weight</p>
<p></p>
<p>List some beneficial effects of bariatric surgery</p>
<p></p>
<p>Reduced diabetes risk
<br></br>Reduced serum triglycerides
<br></br>Increased HDLs
<br></br>Reduced fatty livery
<br></br>Reduced BP</p>
<p></p>
<p>What is the normal range for H+ concentration in ECF?</p>
<p></p>
<p>35-45mmol/L</p>
<p></p>
<p>What equation links H+ to pH</p>
<p></p>
<p>pH = log(1/[H+])</p>
<p></p>
<p>What are the 3 main physiological buffers?</p>
<p></p>
<p>Bicarbonate
<br></br>Haemoglobin
<br></br>Phosphate
<br></br>N.B: Also protein & bone</p>
<p></p>
<p>What is the rate of production of H+ ions per day?</p>
<p></p>
<p>50-100mmol/day</p>
<p></p>
<p>Describe how kidneys excrete H+ ions</p>
<p></p>
<p>HCO3 regenerated through production of carbonic acid</p>
<p></p>
<p>Describe how H+ ions pass through renal epithelium membrane</p>
<p></p>
<p>H+ ions cannot pass through membrane itself so transport system necessary (Na+/H+ exchange)</p>
<p></p>
<p>What is the rate of production of CO2 per day?</p>
<p></p>
<p>20,000-25,000mmol/day</p>
<p></p>
<p>Describe respiratory control over CO2</p>
<p></p>
<p>Respiration controlled by chemoreceptors in hypothalamic respiratory centre
<br></br>Increase in CO2 will stimulate increase in ventilation which then brings down CO2 concentration</p>
<p></p>
<p>What is the primary abnormality in metabolic acidosis? List 3 causes with e.g.s</p>
<p></p>
<p>Primary abnormality increased H+ (with decreased HCO3)
<br></br>Caused by:
<br></br>- Increased H+ production (e.g. DKA)
<br></br>- Decreased H+ excretion (e.g. renal tubular acidosis)
<br></br>HCO3 loss (e.g. intestinal fistula)</p>
<p></p>
<p>What is the primary abnormality in respiratory acidosis? List 3 causes with e.g.s</p>
<p></p>
<p>Primary abnormality increased CO2 (therefore, increased H+) & slight increase in HCO3
<br></br>Caused by:
<br></br>- Decreased ventilation
<br></br>- Poor lung perfusion
<br></br>- Impaired gas exchange
<br></br>N.B: Metabolic compensation slower than respiratory compensation</p>
<p></p>
<p>What is the primary abnormality in metabolic alkalosis? List 3 causes with e.g.s</p>
<p></p>
<p>Primary abnormality decreased H+ (with increased HCO3)
<br></br>Caused by:
<br></br>- H+ loss (e.g. pyloric stenosis)
<br></br>- Hypokalaemia
<br></br>- Ingestion of HCO3</p>
<p></p>
<p>What is the primary abnormality in respiratory alkalosis? List 3 causes with e.g.s</p>
<p></p>
<p>Primary abnormality reduced CO2
<br></br>If prolonged, can lead to reduced renal H+ excretion & reduced HCO3 generation
<br></br>Can be caused by hyperventilation due to:
<br></br>- Voluntary
<br></br>- Artificial ventilation
<br></br>- Stimulation of respiratory centre</p>
<p></p>
<p>What derangement of acid-base balance would be caused by pyloric stenosis?</p>
<p></p>
<p>Metabolic alkalosis due to loss of H+ from profuse vomiting</p>
<p></p>
<p>Which condition classically causes mixed respiratory alkalosis & metabolic acidosis?</p>
<p></p>
<p>Aspirin overdose
<br></br>Aspirin stimulates ventilation & reduces renal excretion of H+</p>
<p></p>
<p>Describe arrangement of hepatocytes within liver</p>
<p></p>
<p>Hepatocytes arranged in trabeculae with sinusoids between them</p>
<p></p>
<p>What are the 3 main components of portal triad?</p>
<p></p>
<p>Portal vein
<br></br>Hepatic artery
<br></br>Bile duct</p>
<p></p>
<p>Describe arrangement of endothelial cells within hepatic sinusoids</p>
<p></p>
<p>Endothelial cells discontinous
<br></br>Spaces between hepatocytes & endothelium of sinusoids called space of Disse
<br></br>This space allows blood to come into contact with liver enzymes</p>
<p></p>
<p>Describe the differences between zone 1 and zone 3</p>
<p></p>
<p>Zone 1 (closer to portal triad) - receives highest O2 concentration
<br></br>Zone 3 (closer to central vein) - receives lowest O2 concentration, therefore most vulnerable to hypoxia. Most metabolically active zone</p>
<p></p>
<p>Which investigations performed if pre-hepatic cause of jaundice suspected?</p>
<p></p>
<p>FBC
<br></br>Blood film</p>
<p></p>
<p>What reaction is used to measure fractions of bilirubin? Describe how this works</p>
<p></p>
<p>Van den Bergh reaction
<br></br>Direct reaction measures conjugated bilirubin
<br></br>Methanol added which completes reaction & gives value for total bilirubin
<br></br>Difference between these 2 values used to measure unconjugated bilirubin (indirect reaction)</p>
<p></p>
<p>What is the most common cause of paediatric jaundice?</p>
<p></p>
<p>Physiological jaundice
<br></br>Neonates have immature livers that cannot conjugate bilirubin fast enough resulting in unconjugated hyperbilirubinaemia</p>
<p></p>
<p>Describe how phototherapy for jaundice works</p>
<p></p>
<p>Phototherapy converts unconjugated bilirubin into lumirubin & photobilirubin which are soluble & don't require conjugation for excretion</p>
<p></p>
<p>What is the inheritance pattern of Gilbert's syndrome?</p>
<p></p>
<p>Autosomal recessive</p>
<p></p>
<p>Which drug can reduce bilirubin levels in Gilbert's syndrome?</p>
<p></p>
<p>Phenobarbital</p>
<p></p>
<p>Outline pathophysiology of Gilbert's syndrome?</p>
<p></p>
<p>UGP glucoronyl transferase activity reduced to 30% of normal
<br></br>Unconjugated bilirubin tightly albumin bound & doesn't enter urine</p>
<p></p>
<p>What can worsen bilirubin levels in Gilbert's syndrome?</p>
<p></p>
<p>Fasting</p>
<p></p>
<p>Describe how urobilinogen formed. What is the significance of absent urobilinogen into urine?</p>
<p></p>
<p>Bilirubin released into bowels will be converted by bacteria in colon into urobilinogen & stercobilinogen
<br></br>Some urobilinogen will be absorbed & transported via enterohepatic circulation to liver
<br></br>Some of this urobilinogen will then be excreted in urine
<br></br>Presence of urobilinogen in urine is normal
<br></br>Absence of urobilinogen in urine suggestive of biliary obstruction</p>
<p></p>
<p>Outline how hepatitis A serology changes over time</p>
<p></p>
<p>As viral titres start to drop following initial infection, there will be a rise in IgM Ab (during this time you will be unwell with jaundice)
<br></br>After a few wks, will start to produce IgG Ab (leading to cure & ongoing protection from Hep A)
<br></br>N.B: Hep A doesn't recur</p>
<p></p>
<p>Name the vaccine for hepatitis A</p>
<p></p>
<p>Havrix (contains some Ags)</p>
<p></p>
<p>Outline the features of hepatitis B serology in acute infection</p>
<p></p>
<p>Initial rise in HBeAg & HBsAg
<br></br>Eventually will develop HBeAb & HBsAb resulting in decline in HBeAg & HBsAg
<br></br>Will also develop HBcAb which suggests previous infection
<br></br>N.B: There is currently no way of diretly measuring HBcAg</p>
<p></p>
<p>Outline the features of hepatitis B serology in someone who has been vaccinated</p>
<p></p>
<p>Will have HBsAb but no other Abs
<br></br>This is because vaccine consists of administering HBsAg only</p>
<p></p>
<p>Outline the features of hepatitis B serology in chronic carrier</p>
<p></p>
<p>Pt will mount immune response but will never clear the virus
<br></br>HBeAg will decline but HBsAg will persist</p>
<p></p>
<p>Describe histology of hepatitis</p>
<p></p>
<p>Hepatocytes will become fatty & swell (balloon cells), containing a lot of Mallory hyaline
<br></br>There will also be a lot of neutrophil polymorphs</p>
<p></p>
<p>What are the defining & associated histological features of alcoholic hepatitis?</p>
<p></p>
<p>Defining: Liver cell damage, inflammation, fibrosis
<br></br>Associated: Fatty change, megamitochondria</p>
<p></p>
<p>List differential diagnoses for fatty liver disease</p>
<p></p>
<p>NASH (most common cause of liver disease in the Western world)
<br></br>Alcoholic hepatitis
<br></br>Malnourishment (Kwashiorkor)</p>
<p></p>
<p>Outline treatment of alcoholic hepatitis</p>
<p></p>
<p>Supportive
<br></br>Stop alcohol
<br></br>Nutrition (vitamins especially thiamine)
<br></br>Occasionally steroids (controversial but may have useful anti-inflammatory effects)</p>
<p></p>
<p>What is the issue with regeneration of hepatocytes following alcohol-related damage?</p>
<p></p>
<p>Regenerate in disorganised manner & produce lots of nodules
<br></br>Disorganised growth interferes with blood flowing through liver leading to rise in portal pressure</p>
<p></p>
<p>Why is Pabrinex yellow?</p>
<p></p>
<p>Presence of riboflavin (B2)</p>
<p></p>
<p>What conditions are caused by the following vitamin deficiencies:
<br></br>- B1
<br></br>- B3</p>
<p></p>
<p>B1
<br></br>- Beri Beri
<br></br>
<br></br>B3
<br></br>- Pellagra</p>
<p></p>
<p>List some features of chronic alcoholic liver disease</p>
<p></p>
<p>Palmar erythema
<br></br>Spider naevi
<br></br>Gynaecomastia (due to failure of liver to break down oestradiol)
<br></br>Dupuytren's contracture</p>
<p></p>
<p>List some features of portal hypertension</p>
<p></p>
<p>Visible veins (oesophageal, rectal, umbilical)
<br></br>Ascites
<br></br>Splenomegaly</p>
<p></p>
<p>What is flapping tremor caused by?</p>
<p></p>
<p>Hepatic encephalopathy</p>
<p></p>
<p>What is liver failure defined by?</p>
<p></p>
<p>Failed synthetic function
<br></br>Failed clotting factor & albumin production
<br></br>Failed clearance of bilirubin
<br></br>Failed clearance of ammonia</p>
<p></p>
<p>Which type of cirrhosis is alcohol typically associated with?</p>
<p></p>
<p>Micronodular cirrhosis
<br></br>N.B: This is because the hepatocytes regenerate within fibrous cuff</p>
<p></p>
<p>What is intrahepatic shunting?</p>
<p></p>
<p>Bridge of fibrosis between portal tracts & central veins means that blood doesn't come into close contact with hepatocytes & get filtered</p>
<p></p>
<p>Which type of jaundice associated with itching? What causes the itching?</p>
<p></p>
<p>Obstructive jaundice
<br></br>Itching caused by bile salts & bile acids</p>
<p></p>
<p>What is Courvoisier's law?</p>
<p></p>
<p>If gallbladder palpable in jaundiced patient, cause is unlikely to be gallstones (i.e. more likely to be pancreatic cancer)</p>
<p></p>
<p>Where does pancreatic cancer tend to metastasise to?</p>
<p></p>
<p>Liver</p>
<p></p>
<p>What are the main consequences of deficient enzyme activity in the context of inherited metabolic disorders?</p>
<p></p>
<p>Lack of end-product
<br></br>Build-up of precursors
<br></br>Abnormal or toxic metabolites</p>
<p></p>
<p>What are the criteria for inherited metabolic disorder screening? (Wilson & Junger criteria)</p>
<p></p>
<p>- Important health problem
<br></br>- Accepted treatment
<br></br>- Facilities for diagnosis & treatment
<br></br>- Latent or early symptomatic stage
<br></br>- Suitable test or examination
<br></br>- Test should be acceptable to population
<br></br>- Natural history of disorder is understood
<br></br>- Agreed policy on whom to treat as patients
<br></br>- Economically balanced
<br></br>- Continuing process (keep updating what is screened for)</p>
<p></p>
<p>What is phenylketonuria caused by</p>
<p></p>
<p>Phenylalanine hydroxylase deficiency
<br></br>Responsible for converting phenylalanine to tyrosine
<br></br>Deficiency results in accumulation of phenylalanine which is toxic</p>
<p></p>
<p>Which abnormal metabolites are produced in PKU?</p>
<p></p>
<p>Phenylpyruvate
<br></br>Phenylacetic acid (detected in urine)</p>
<p></p>
<p>What is the main consequnce of untreated PKU?</p>
<p></p>
<p>Low IQ</p>
<p></p>
<p>How is PKU investigated?</p>
<p></p>
<p>Blood phenylalanine level</p>
<p></p>
<p>Describe the treatment of PKU</p>
<p></p>
<p>Monitor the diet & ensure that the patient is having enough phenylalanine (but not too much)
<br></br>This must be started within the first 6wks of life</p>
<p></p>
<p>When is the Guthrie test performed in the UK?</p>
<p></p>
<p>5-8 days after birth</p>
<p></p>
<p>What is congenital hypothyroidism usually caused by?</p>
<p></p>
<p>Thyroid dysgenesis or agenesis
<br></br>N.B: Diagnosis based on high TSH</p>
<p></p>
<p>Describe the pathophysiology of MCAD deficiency</p>
<p></p>
<p>Fatty acid oxidation disorder
<br></br>The carnitine shuttle transports fats into the mitochondria where it will be broken down into smaller & smaller chains by the process of fatty acid oxidation
<br></br>Without MCAD, will not produce acetyl-CoA from fatty acids, which is necessary in the TCA cycle to produce ketones (which spares glucose)
<br></br>Fat is used when fasting in between meals in order to spare glucose stores
<br></br>In MCAD deficiency, the patient is unable to break down fats so they become very hypoglycaemic (as can't produce ketones) in between meals & thus can die</p>
<p></p>
<p>What is the screening test for MCAD deficiency?</p>
<p></p>
<p>Measuring C6-C10 acylcarnitines by tandem mass spectrometry</p>
<p></p>
<p>Outline the treatment of MCAD deficiency</p>
<p></p>
<p>Make sure child never becomes hypoglycaemic, & hence reliant on fats as source of energy</p>
<p></p>
<p>What is homocysturia caused by?</p>
<p></p>
<p>Failure of remethylation of homocysteine</p>
<p></p>
<p>What are the clinical features of homocystinuria?</p>
<p></p>
<p>Lens dislocation
<br></br>Mental retardation
<br></br>Thromboembolism</p>
<p></p>
<p>Which conditions are screened for by the Guthrie test?</p>
<p></p>
<p>Sickle cell disease
<br></br>Cystic fibrosis
<br></br>Congenital hypothyroidism
<br></br>Inherited metabolic diseases:
<br></br>- Phenylketonuria (PKU)
<br></br>- Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
<br></br>- Maple syrup urine disease (MSUD)
<br></br>- Isovaleric acidaemia (IVA)
<br></br>- Glutaric aciduria type 1 (GA1)
<br></br>- Homocystinuria (HCU)</p>
<p></p>
<p>Outline the pathophysiology of cystic fibrosis</p>
<p></p>
<p>Failure of cystic fibrosis transmembrane conductance regulator (CFTR) means that chloride ions cannot move into lumen from cells, resulting in increased water absorption & very thick secretions</p>
<p></p>
<p>What is the screening test for cystic fibrosis?</p>
<p></p>
<p>High serum immune reactive trypsinogen (IRT)</p>
<p></p>
<p>Describe the process of screening & diagnosis of cystic fibrosis?</p>
<p></p>
<p>If IRT >99.5th centile in 3 bloodspots, move on to mutation detection
<br></br>>500 mutations that can cause CF, but 4 are very common
<br></br>If detect 2/4 mutations, diagnose CF
<br></br>If detect 1/4 mutations, extend test to panel of 28 mutations
<br></br>If detect 0/4 mutations, repeat IRT at day 21-28</p>
<p></p>
<p>Why is it difficult to get an ammonia sample?</p>
<p></p>
<p>Need a free-flowing sample, which needs to be put in ice & rushed to lab</p>
<p></p>
<p>What is the main role of the urea cycle</p>
<p></p>
<p>Taking ammonia & producing urea</p>
<p></p>
<p>How many enzymes are there in the urea cycle?</p>
<p></p>
<p>7</p>
<p></p>
<p>Name 3 other diseases that count as urea cycle defects</p>
<p></p>
<p>Lysinuric protein intolerance
<br></br>Hyperornithaemia-hyperammonaemia-homocitrullinuria
<br></br>Citrullinuria type II</p>
<p></p>
<p>What do all urea cycle disorders result in?</p>
<p></p>
<p>High ammonia - this is toxic</p>
<p></p>
<p>What is the mode of inheritance of almost all of these urea cycle defects? What is the exception?</p>
<p></p>
<p>Autosomal recessive
<br></br>Ornithine transcarbamylase deficiency (X-linked)</p>
<p></p>
<p>How does the body get rid of excess ammonia?</p>
<p></p>
<p>Ammonium group attached to glutamate to make glutamine
<br></br>So, plasma glutamine in hyperammonaemic conditions will be high
<br></br>N.B: The amino acids within the urea cycle will be high or absent. You can also measure urine orotic acid</p>
<p></p>
<p>What is the treatment of urea cycle disorders?</p>
<p></p>
<p>Remove ammonia (using sodium benzoate, sodium phenylacetate, or dialysis)
<br></br>Remove ammonia production (low protein diet)</p>
<p></p>
<p>Why might patients with urea cycle disorders have slight build?</p>
<p></p>
<p>Patients may subconsciously avoid protein because they know it makes them feel ill</p>
<p></p>
<p>List the key features of urea cycle disorders</p>
<p></p>
<p>Vomiting without diarrhoea
<br></br>Respiratory alkalosis
<br></br>Hyperammonaemia
<br></br>Encephalopathy
<br></br>Avoidance or change in diet</p>
<p></p>
<p>What tends to cause hyperammonaemia with metabolic acidosis & high anion gap?</p>
<p></p>
<p>Organic acidurias
<br></br>Also caused by defects in the complex metabolism of branched chain amino acids</p>
<p></p>
<p>List 3 branched chain amino acids</p>
<p></p>
<p>Leucine
<br></br>Isoleucine
<br></br>Valine</p>
<p></p>
<p>Describe the breakdown of leucine</p>
<p></p>
<p>Ammonia group will be broken off using a transaminase & high energy protein group will be added
<br></br>This produces a breakdown product, isovaleryl CoA
<br></br>Then converted by isovaleryl CoA dehydrogenase
<br></br>Molecules with high energy groups cannot cross the cell membrane, so need to be converted to other molecules:
<br></br>- Export from cell as: Isovaleryl carnitine
<br></br>- Excrete as: 3OH-isovaleric acid (cheesy smell) & isovaleryl glycine</p>
<p></p>
<p>Describe the presenting features of organic acidurias in neonates</p>
<p></p>
<p>Unusual odour
<br></br>Lethargy
<br></br>Feeding problems
<br></br>Truncal hypotonia/limb hypertonia
<br></br>Myoclonic jerks</p>
<p></p>
<p>Describe the chronic intermittent form of organic acidurias</p>
<p></p>
<p>Recurrent episodes of ketoacidotic coma
<br></br>Cerebral abnormalities</p>
<p></p>
<p>What is Reye's syndrome?</p>
<p></p>
<p>Rapidly progressive encephalopathy that can be triggered by aspirin use in children (also triggered by antiemetics & valproate)</p>
<p></p>
<p>Describe the features of Reye's syndrome</p>
<p></p>
<p>Vomiting
<br></br>Lethargy
<br></br>Increased confusion
<br></br>Seizures
<br></br>Decerebration
<br></br>Respiratory arrest</p>
<p></p>
<p>What would constitute the metabolic screen for Reye's syndrome?</p>
<p></p>
<p>Plasma ammonia
<br></br>Plasma/urine amino acids
<br></br>Urine organic acids
<br></br>Plasma glucose & lactate
<br></br>Blood spot carnitine profiles (stays abnormal in remission)
<br></br>N.B: Top 4 need to be measured during an acute episode because the abnormal metabolites will disappear after a few days</p>
<p></p>
<p>What do defects in mitochondrial fatty acid beta oxidation cause?</p>
<p></p>
<p>Hypoketotic hypoglycaemia
<br></br>N.B: Means unable to make ketones in between meals as an alternative energy source</p>
<p></p>
<p>Which investigations are useful for defects in mitochondrial fatty acid beta oxidation?</p>
<p></p>
<p>Blood ketones
<br></br>Urine organic acids
<br></br>Blood spot acylcarnitine profile</p>
<p></p>
<p>What is galactosaemia?</p>
<p></p>
<p>Disorder of galactose metabolism resulting in high levels of galactose in the blood</p>
<p></p>
<p>What is the most severe & most common form of galactosaemia?</p>
<p></p>
<p>Galacactose-1-phosphate uridyl transferase (Gal-1-PUT) deficiency
<br></br>N.B: High galactose-1-phosphate results in liver & kidney disease</p>
<p></p>
<p>Describe the presentation of galactosaemia</p>
<p></p>
<p>Vomiting & diarrhoea
<br></br>Conjugated hyperbilirubinaemia
<br></br>Hepatomegaly
<br></br>Hypoglycaemia
<br></br>Sepsis (galactose-1-phosphate inhibits the immune response)</p>
<p></p>
<p>What is a long-term complication of galactosaemia if it not detected in the neonatal period?</p>
<p></p>
<p>Bilateral cataracts
<br></br>High concentration of galactose-1-phosphate end up being substrate for aldolase which is found in the lens of the eye</p>
<p></p>
<p>List some investigations for galactosaemia</p>
<p></p>
<p>Urine reducing substances (high levels of galactose)
<br></br>Red cell Gal-1-PUT</p>
<p></p>
<p>What is the treatment for galactosaemia?</p>
<p></p>
<p>Avoid galactose (e.g. milk)</p>
<p></p>
<p>Describe the pathophysiology of glycogen storage disease type I</p>
<p></p>
<p>Whenever glycogen broken down, it produces glucose-1-phosphate & glucose 6-phosphate. Phosphate groups must be removed so can cross cell membrane. Lack of phosphatase means G1P & G6P cannot be exported. Means muscles & liver build up a lot of glycogen that can't be liberated leading to hypoglycaemia
<br></br>N.B: aka von Gierke disease</p>
<p></p>
<p>What are the clinical features of glycogen storade disease type I?</p>
<p></p>
<p>Hepatomegaly
<br></br>Nephromegaly
<br></br>Hypoglycaemia
<br></br>Lactic acidosis
<br></br>Neutropaenia</p>
<p></p>
<p>What does 'heteroplasmy' mean with regards to mitochondrial DNA?</p>
<p></p>
<p>Once reach certain load of abnormal mitochondrial DNA, will start to develop symptoms</p>
<p></p>
<p>Which organs tend to be affected by mitochondrial disorders?</p>
<p></p>
<p>Defective ATP production leads to issue in organs with high energy demand (e.g. brain, muscle, kidney, retina, endocrine organs)</p>
<p></p>
<p>List 3 e.g. of mitochondrial diseases & outline their manifestations</p>
<p></p>
<p>Barth syndrome
<br></br>- Cardiomyopathy, neutropaenia, & myopathy starting at birth
<br></br>
<br></br>MELAS
<br></br>- Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes
<br></br>
<br></br>Kearns-Sayre syndrome
<br></br>- Chronic progressive external ophthalmoplegia, retinopathy, deafness, & ataxia</p>
<p></p>
<p>List some investigations for mitochondrial diseases</p>
<p></p>
<p>High lactate (alanine) - especially after periods of fasting (N.B: Normally would expect to decrease when fasting)
<br></br>CSF lactate/pyruvate
<br></br>CSF protein (elevated in Kearns-Sayre)
<br></br>CK
<br></br>Muscle biopsy
<br></br>Mitochondrial DNA analysis</p>
<p></p>
<p>What is the characteristic appearance of mitochondrial myopathy on a muscle biopsy?</p>
<p></p>
<p>Ragged red fibres</p>
<p></p>
<p>What are congenital disorders of glycosylation? Give an e.g.</p>
<p></p>
<p>Defect of post-translational protein glycosylation
<br></br>Multisystem disorder associated with cardiomyopathy, osteopaenia, & hepatomegaly
<br></br>E.g.: CDG type 1a - abnormal subcutaneous adipose distribution with fat pads & nipple retraction</p>
<p></p>
<p>What is the average birthweight of a baby born at term?</p>
<p></p>
<p>M: 3.3kg
<br></br>F: 3.2kg</p>
<p></p>
<p>List some common problems in LBW babies</p>
<p></p>
<p>Respiratory distress syndrome
<br></br>Retinopathy of prematurity
<br></br>Intraventricular haemorrhage
<br></br>Patent ductus arteriosus
<br></br>Nectrotising enterocolitis</p>
<p></p>
<p>What is necrotising enterocolitis</p>
<p></p>
<p>Inflammation of bowel wall progressing to necrosis & perforation
<br></br>Characterised by bloody stools, abdominal distension, & intramural air (pneumatosis intestinalis)</p>
<p></p>
<p>In developing foetus, when do:
<br></br>- Nephrons develop
<br></br>- Start producing urine
<br></br>- Have fully competent nephrons
<br></br>- Achieve functional maturity of glomerular function</p>
<p></p>
<p>Nephrons develop
<br></br>- Wk 6
<br></br>
<br></br>Start producing urine
<br></br>- Wk 10
<br></br>
<br></br>Have fully competent nephrons
<br></br>- Wk 36
<br></br>
<br></br>Achieve functional maturity of glomerular function
<br></br>- 2yrs</p>
<p></p>
<p>What are the implications of large SA:V of babies?</p>
<p></p>
<p>Low GFR for SA
<br></br>Results in slow excretion of solute load
<br></br>Limited Na+ available for H+ exchange</p>
<p></p>
<p>List some key differences of neonatal kidneys compared to adult kidneys & their complications</p>
<p></p>
<p>Short proximal tubule so lower reabsorptive capability
<br></br>Reduce resorption of HCO3 leading to propensity to acidosis
<br></br>Loop of Henle & distal collecting ducts short & juxtaglomerular leading to reduced concentrating ability (max urine osmolality = 700mmol/kg)
<br></br>Distal tubule relatively unresponsive to aldosterone leading to persistent Na loss & reduced K excretion (Na loss = 1.8mmol/kg/day & upper limit of normal K = 6mmol/L in neonates)</p>
<p></p>
<p>Why does glycosuria occur at lower plasma glucose level in neonates?</p>
<p></p>
<p>Short proximal tubule means that they have lower ability to reabsorb glucose</p>
<p></p>
<p>Describe how body water content is different in neonates compared to adults</p>
<p></p>
<p>Term neonates 75% water compared to 60% in adults (& 85% in preterm infants)</p>
<p></p>
<p>What happens to the body water content in 1st wk of life?</p>
<p></p>
<p>Pulmonary resistance drops & get release of ANP leading to fluid redistribution
<br></br>Can lead to up to 10% weight loss within 1st wk of life
<br></br>Roughly 40mL/kg in preterm infants</p>
<p></p>
<p>How are daily fluid & electrolyte requirements different in neonates compared to adults?</p>
<p></p>
<p>Na, K, & water requirements higher
<br></br>N.B: Na requirements particularly high in preterm neonates (<30wks), so plasma Na should be measured daily in these patients. K supplements should be given once urine output >1mL/kg/hr has been achieved</p>
<p></p>
<p>Why do babies have higher insensible water loss?</p>
<p></p>
<p>High SA
<br></br>Increased skin blood flow
<br></br>High respiratory rate & metabolic rate
<br></br>Increased transdermal fluid loss
<br></br>N.B: Skin not keratinised in premature infants</p>
<p></p>
<p>Drugs can cause electrolyte disturbances in neonates. Give e.g.s of drugs that can do this & briefly describe the mechanism</p>
<p></p>
<p>HCO3 for acidosis (contains high Na)
<br></br>Abx (usually Na salts)
<br></br>Caffeine/theophylline (for apneoa) - increases renal Na loss
<br></br>Indomethacin (for PDA) - causes oliguria
<br></br>N.B: Growth can also cause electrolyte disturbance</p>
<p></p>
<p>What is hypernatraemia usually caused by in neonates?</p>
<p></p>
<p>Dehydration
<br></br>N.B: Usually uncommon after 2wks
<br></br>N.B: Food poisoning & osmoregulatory dysfunction are differentials</p>
<p></p>
<p>What is hyponatraemia usually caused by in neonates?</p>
<p></p>
<p>Congenital adrenal hyperplasia</p>
<p></p>
<p>Outline the pathophysiology of congenital adrenal hyperplasia</p>
<p></p>
<p>Most commonly caused by 21-hydroxylase deficiency
<br></br>Leads to reduced cortisol & aldosterone production & shunting of 17-OH progesterone & 17-OH pregnenolone which goes towards androgen synthesis</p>
<p></p>
<p>Outline clinical features of congenital adrenal hyperplasia</p>
<p></p>
<p>Hyponatraemia/hyperkalaemia
<br></br>Hypoglycaemia
<br></br>Ambiguous genitalia in F neonates
<br></br>Growth acceleration</p>
<p></p>
<p>List 3 reasons for neonatal hyperbilirubinaemia</p>
<p></p>
<p>High level of bilirubin synthesis
<br></br>Low rate of transport into liver
<br></br>Enhanced enterohepatic circulation</p>
<p></p>
<p>How much bilirubin can 1g/L of albumin bind?
<br></br>
<br></br>How much albumin does the average term neonate have? How much bilirubin can this albumin bind?</p>
<p></p>
<p>10mcmol/L/g albumin
<br></br>
<br></br>34g/L albumin
<br></br>340mcmol/L of bilirubin</p>
<p></p>
<p>What is the issue with free bilirubin?</p>
<p></p>
<p>Can cross the blood-brain barrier leading to kernicterus</p>
<p></p>
<p>What are the 3 bilirubin thresholds in neonates? (i.e. What treatments are given at these thresholds?)</p>
<p></p>
<p>No treatment
<br></br>Phototherapy
<br></br>Exchange transfusion</p>
<p></p>
<p>List some causes of neonatal jaundice</p>
<p></p>
<p>G6PD deficiency
<br></br>Haemolytic anaemia (ABO, rhesus)
<br></br>Crigler-Najjar syndrome</p>
<p></p>
<p>What is prolonged jaundice?</p>
<p></p>
<p>Jaundice that lasts >14 days in term babies, or >21 days in preterm babies</p>
<p></p>
<p>List some causes of prolonged jaundice in neonates</p>
<p></p>
<p>Prenatal infection/sepsis
<br></br>Hypothyroidism
<br></br>Breast milk jaundice</p>
<p></p>
<p>What level of conjugated hyperbilirubinaemia considered pathological?</p>
<p></p>
<p>>20mcmol/L</p>
<p></p>
<p>List some causes of conjugated hyperbilirubinaemia</p>
<p></p>
<p>Biliary atresia (most common)
<br></br>Choledochal cyst
<br></br>Ascending cholangitis in TPN
<br></br>Inherited metabolic diseases (e.g. galactosaemia, alpha-1 antitrypsin deficiency, tyrosinaemia, peroxismal disorders)
<br></br>N.B: 20% of biliary atresia associated with cardiac malformations, polysplenia, situs inversus</p>
<p></p>
<p>At which point during pregnancy is most Ca & PO4 laid down?</p>
<p></p>
<p>Third trimester</p>
<p></p>
<p>How are Ca & PO4 levels different in babies?</p>
<p></p>
<p>After birth, Ca levels will fall
<br></br>PO4 higher in babies (they are good at reabsorbing it)</p>
<p></p>
<p>List the main biochemical features of osteopaenia of prematurity</p>
<p></p>
<p>Ca usually normal
<br></br>PO4 <1mmol/L
<br></br>ALP >1200U/L (10x adult upper limit of normal)</p>
<p></p>
<p>How is osteopaenia of prematurity treated?</p>
<p></p>
<p>PO4/Ca supplements
<br></br>1-alpha calcidol</p>
<p></p>
<p>List some presenting features of rickets</p>
<p></p>
<p>Frontal bossing
<br></br>Bowed legs
<br></br>Muscular hypotonia
<br></br>Tetany/hypocalcaemic seizure
<br></br>Hypocalcaemic cardiomyopathy</p>
<p></p>
<p>List some genetic causes of rickets</p>
<p></p>
<p>Pseudo-vitamin D deficiency I (defective renal hydroxylation)
<br></br>Pseudo-vitamin D deficiency II (receptor defect)
<br></br>Familial hypophosphataemia (low tubular max reabsorption of phosphate, raised urine phosphoethanolamine)
<br></br>N.B: Top 2 conditions treated with 1,25-OH vitamin D</p>
<p></p>
<p>What is porphyria?</p>
<p></p>
<p>Disorders caused by deficiencies in enzyme sof haem synthesis pathway
<br></br>Leads to accumulation of toxic haem precursors</p>
<p></p>
<p>What are the 2 ways in which porphyria can manifest?</p>
<p></p>
<p>Acute neurovisceral attacks
<br></br>Acute or chornic cutaneous symptoms</p>
<p></p>
<p>List some key features of haem</p>
<p></p>
<p>Organic heterocyclic compound with Fe2+ in centre
<br></br>Tetrapyrrole ring around the Fe</p>
<p></p>
<p>Where is haem found?</p>
<p></p>
<p>Erythroid cells
<br></br>Liver cytochrome</p>
<p></p>
<p>Draw the haem synthesis pathway</p>
<p></p>
<p>Which component of this pathway is neurotoxic?</p>
<p></p>
<p>5-ALA</p>
<p></p>
<p>What types of porphyrin may be produced in absence of Fe</p>
<p></p>
<p>Metal-free protoporphyrins
<br></br>Zinc protoporphyrin</p>
<p></p>
<p>How can porphyrias be classified?</p>
<p></p>
<p>Principle site of enzyme deficiency
<br></br>- Erythroid
<br></br>- Hepatic
<br></br>
<br></br>Clinical presentation
<br></br>- Acute or non-acute
<br></br>- Neurovisceral or skin lesions</p>
<p></p>
<p>Outline the relationships between UV light & skin lesions</p>
<p></p>
<p>Porphyrinogens oxidised & activated by UV light into activated porphyrins
<br></br>N.B: Porphyrins don't oxidise in cells</p>
<p></p>
<p>What is key difference between porphyrinogens & porphyrins?</p>
<p></p>
<p>Porphyrinogens - colourless, unstable, & readily oxidised to porphyrin
<br></br>Porphyrins - highly coloured</p>
<p></p>
<p>Which porphyrins appear in urine & faeces?</p>
<p></p>
<p>Urine - uroporphyrins are water-soluble
<br></br>Faeces - coproporphyrins less soluble & near end of pathway
<br></br>N.B: Someone with porphyria will have colourless/yellow urine which turns red/dark red/purple as porphyrinogens oxidised & activated into porphyrins</p>
<p></p>
<p>List 4 types of acute porphyria & enzymes involved</p>
<p></p>
<p>Plumboporphyria - PBG synthase
<br></br>Acute intermittent porphyria - HMB synthase
<br></br>Hereditary coproporphyria - coproporphyrinogen oxidase
<br></br>Variegate porphyria - protoporphyrinogen oxidase</p>
<p></p>
<p>List 3 types of non-acute porphyria & enzymes involved</p>
<p></p>
<p>Congenital erythropoietic porphyria - uroporphyrinogen III synthase
<br></br>Porphyria cutanea tarda - uroporphyrinogen decarboxylase
<br></br>Erythropoietic protoporphyria - ferrochetolase</p>
<p></p>
<p>What is most common type of porphyria?</p>
<p></p>
<p>Porphyria cutanea tarda</p>
<p></p>
<p>What is most common type of porphyria in children?</p>
<p></p>
<p>Erythropoietic protoporphyria</p>
<p></p>
<p>What does ALA synthase deficiency cause?</p>
<p></p>
<p>X-linked sideroblastic anaemia</p>
<p></p>
<p>How can mutation in ALA synthase lead to porphyria?</p>
<p></p>
<p>Gain-of-function mutation will result in increased throughput through pathway leading to build-up in protoporphyrin IX as overwhelms ability of ferrochetolase to convert into haem</p>
<p></p>
<p>What are main features of PBG synthase deficiency?</p>
<p></p>
<p>Causes acute porphyria
<br></br>Leads to accumulation of ALA
<br></br>Abdominal pain (most important feature)
<br></br>Neurological symptoms (e.g. coma, bulbar palsy, motor neuropathy)</p>
<p></p>
<p>Which deficiency causes acute intermittent porphyria?</p>
<p></p>
<p>HMB synthase (aka PBG deaminase)</p>
<p>Outline clinical features of acute intermittent porphyria</p>
<p>Rise in PBG & ALA
<br></br>Autosomal dominant
<br></br>Neurovisceral attacks
<br></br>- Abdominal pain
<br></br>- Tachycardia & hypertension
<br></br>- Constipation, urinary incontinence
<br></br>- Hyponatraemia & seizures
<br></br>- Sensory loss/muscle weakness
<br></br>- Arrhythmias/cardiac arrest
<br></br>
<br></br>Important: No skin symptoms (because no porphyrinogens produced)
<br></br>N.B: 90% asymptomatic</p>
<p>List some precipitating factors for acute intermittent porphyria</p>
<p>ALA synthase inhibitors (e.g. steroids, ethanol, anticonvulsants (CYP450 inducers))
<br></br>Stress (infection, surgery)
<br></br>Reduced caloric intake
<br></br>Endocrine factors</p>
<p>Describe how acute intermittent porphyria diagnosed</p>
<p>Increased urinary PBG (& ALA)
<br></br>PBG gets oxidised to porphobilin
<br></br>Decreased HMB synthase activity in erythrocytes</p>
<p>How is acute intermittent porphyria managed?</p>
<p>Avoid attacks (adequate nutrition, avoid precipitant drug, prompt treatment of other illnesses)
<br></br>IV carbohydrate (inhibits ALA synthase)
<br></br>IV haem arginate (switches off haem synthesis through -ve feedback)</p>
Name 2 acute porphyrias that have skin manifestations. State the enzymes affected.
Hereditary coproporphyria - coproporphyrinogen oxidase
Variegate porphyria - protoporphyrinogen oxidase
What is the -ve consequence of accumulation of coproporphyrinogen III & protoporphyrinogen IX?
Potent inhibitors of HMB synthase
Results in accumulation of PBG & ALA
What are the main clinical features of hereditary coproporphyria?
Autosomal dominant Acute neurovisceral attacks Skin lesions (blistering, skin fragility, classically on backs of hands that tend to appear hrs/days after sun exposure)
What are the main clinical features of variegate porphyria?
Autosomal dominant
Acute attacks with skin lesions
How is the porphyrin level in urine & faeces different in hereditary coproporphyria & variegate porphyria compared to acute intermittent porphyria?
AIP - normal
HCP & VP - high
N.B: DNA analysis offers definitive diagnosis
What is a common feature of non-acute porphyria?
Only present with skin lesions with no neurovisceral manifestations
List enzymes associated with non-acute porphyria
Uroporphyrinogen III synthase - congenital erythropoietic porphyria
Uroporphyrinogen decarboxylase - porphyria cutanea tarda
Ferrochetolase - erythropoietic protoporphyria
What is the main clinical feature of non-acute porphyria?
Skin blisters, fragility, pigmentations, & erosions, tend to appear hrs/days after sun exposure
What are key features of erythropoietic protoporphyria?
Non-blistering & presents with photosensitivity, burning, itching, oedema, following sun exposure
What is a key investigation for erythropoietic protoporphyria?
RBC protoporphyrin
N.B: Only RBCs affected
What are the key features of porphyria cutanea tarda?
Can be inherited or acquired
Leads to formation of vesicles on sun-exposed areas of skin - crusting, superficial scarring, & pigmentation
Outline biochemistry features of porphyria cutanea tarda
Urine/plasma uroporphyrins & coporphyrins raised
Ferritin often increased
Which drug can trigger porphyria cutanea tarda?
Hexachlorobenzene
What haematalogical condition are erythropoietic protoporphyria & congenital erythropoietic porphyria associated with?
Myelodysplastic syndromes